Aurobindo Pharma continues good show; scrip hits 52-week high

Subscribe to GoodReturns

Aurobindo Pharma continues good show; scrip hits 52-week high
Shares of drug maker Aurobindo Pharma extended gain over 5 per cent in early trade on Bombay Stock Exchange (BSE) with the stock touching 52-week high as investors continued to bet on companies robust performance.

The company had reported a robust operating performance for the second quarter ended September 2013 and had also received the final approval from the U.S. health regulator to manufacture and market DuloxetineHydrochloride Delayed-Release capsules, an anti-depressant drug, in the American market.

Continuing its gaining momentum, shares of company gained as much as 5.47 per cent to trade at Rs 404.80 a piece on the BSE.

In a similar fashion, shares of the company advanced 4.43 per cent 400.80 a piece on National Stock Exchange.

Meanwhile, the broader benchmark Sensex was quoting at 21,124.39, down 23.36 points or 0.11 per cent at 10:12 hours.

Dion Global Solutions Ltd.

Story first published: Tuesday, December 24, 2013, 12:44 [IST]
Please Wait while comments are loading...
Company Search
Enter the first few characters of the company's name or the NSE symbol or BSE code and click 'Go'